Complete financial analysis of Integrated Pharmaceuticals, Inc. (INTP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Integrated Pharmaceuticals, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Broadcom Inc. (AVGO) Income Statement Analysis – Financial Results
- ePlay Digital Inc. (EPY.CN) Income Statement Analysis – Financial Results
- Aecon Group Inc. (ARE.TO) Income Statement Analysis – Financial Results
- Claranova SE (CLA.PA) Income Statement Analysis – Financial Results
- Pershing Square Tontine Holdings, Ltd. (PSTH) Income Statement Analysis – Financial Results
Integrated Pharmaceuticals, Inc. (INTP)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
About Integrated Pharmaceuticals, Inc.
Integrated Pharmaceuticals, Inc. develops and produces specialty chemicals and nutraceuticals in the United States. It offers compounds and nutraceuticals that have proven therapeutic or nutritional value in humans, plants, and animals. The company also develops technologies for the production of clinically active pharmaceutical compounds, including active small molecules and recombinant DNA technology derived products. In addition, it offers calcium supplements that are used in soft drinks, coffee, tea, soup, dehydrated sauces, and beverages; and fortified bottled water. The company sells its products through distributors and retailers. The company was formerly known as Digital Caddies, Inc. and changed its name to Integrated Pharmaceuticals, Inc. in September 2011. The company was incorporated in 1969 and is based in Fitchburg, Massachusetts.
Source: https://incomestatements.info
Category: Stock Reports